Feminax Express

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Feminax Express

Property Description
Active Ingredient Ibuprofen Lysinate
Form Oral (Tablet or Capsule)
Pharmacological Class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General Purpose Analgesic, Anti-inflammatory, and Antipyretic
Origin Synthetic (Propionic acid derivative)

Feminax Express: Definition and Pharmacological Class

Feminax Express is a proprietary Over-The-Counter (OTC) medicine and a branded product, classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This defines it as a synthetically derived medication that may be purchased without a prescription, whose core function is to relieve pain and reduce inflammation. The product is established to possess analgesic (pain-relieving), anti-inflammatory (swelling-reducing), and antipyretic (fever-reducing) effects. The general efficacy of Ibuprofen is clinically recognized for managing mild to moderate discomfort.

Composition and The Ibuprofen Lysinate Form

The single active component in this preparation is Ibuprofen Lysinate, which is the highly soluble lysine salt of the base drug, Ibuprofen. This active substance is delivered in an oral dosage form, typically a film-coated tablet or liquid capsule. The specific use of the Lysinate salt is a chemical modification designed to increase the compound's solubility. This enhanced solubility is intended to facilitate more rapid absorption of the Ibuprofen into the bloodstream when compared to standard free-acid preparations. This accelerated absorption is the key differentiating factor positioning the product for fast action.

General Purpose of the Formulation

The general therapeutic purpose of Feminax Express is to deliver comprehensive and fast-acting symptomatic relief. It functions by inhibiting the synthesis of prostaglandins—local hormones that contribute to the manifestation of pain, fever, and inflammation. By modulating this key process, the medicine simultaneously helps to lessen the pain sensation, reduce swelling, and lower an elevated body temperature. The overall design prioritizes speed and completeness of action for discomfort where both pain and inflammation are factors.

Regulatory References

  1. Ibuprofen - StatPearls - NCBI Bookshelf
  2. Ibuprofen: MedlinePlus Drug Information

What side effects are possible with Feminax Express?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse effects and safety constraints for the active ingredient, Ibuprofen Lysinate, based strictly on government regulatory documents and approved prescribing information. The adverse reactions are categorized by frequency and the body system affected.


Official Adverse Reactions by System-Organ Class

The most frequently reported undesirable effects relate to the Gastrointestinal System.

Frequency Classification Common Adverse Reactions
Common Pyrosis (heartburn), abdominal pain, nausea, vomiting, flatulence, diarrhea, and constipation.
Uncommon Headache, dizziness, sleeplessness, various skin rashes, and mild hypersensitivity reactions.
Very Rare Haematopoietic disorders, severe general hypersensitivity reactions, heart failure, myocardial infarction, and gastrointestinal perforation or bleeding.

Serious Safety Considerations

Regulatory labeling documents the potential for rare but serious adverse reactions. These include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which often pose the highest risk early in the treatment course. The active substance, like other NSAIDs, carries a documented risk of arterial thrombotic events (e.g., stroke or myocardial infarction), particularly associated with high doses and long-term exposure. Gastrointestinal bleeding and ulceration are also serious risks.

Population-Specific Notes

The elderly population has an increased frequency of adverse reactions, specifically the risk of fatal gastrointestinal bleeding. Caution is also noted for patients with a history of asthma, as bronchospasm may be precipitated. Additionally, evidence suggests a potential for reversible impairment of female fertility.

Overdose and Emergency Response

Overdose of Ibuprofen Lysinate may initially present with non-specific central nervous system and gastrointestinal manifestations. Documented symptoms include drowsiness, dizziness, headache, confusion, nausea, vomiting, abdominal pain, and ringing in the ears (tinnitus).

Of greater concern are serious, life-threatening outcomes documented in regulatory labeling. These include severe gastrointestinal hemorrhage and ulceration, acute kidney failure, metabolic acidosis, and severe hypotension. Neurological events such as seizures and coma have also been reported. The risk of cardiovascular events, including heart attack or stroke, is noted as higher when the recommended maximum dose is exceeded.

In any case of suspected overdose, prompt medical attention is critical. Regulatory bodies mandate that individuals get medical help or contact a Poison Control Center right away, even if no initial signs are immediately noticeable. Urgent care is required if symptoms of internal bleeding (e.g., bloody or black stools, vomiting blood) or cardiovascular complications (e.g., chest pain, slurred speech) occur.

Management is entirely symptomatic and supportive, as official prescribing information confirms that no specific antidote is known. Hospital monitoring of vital signs is required, and patients must be followed for several days due to the risk of delayed gastrointestinal complications. The elderly population is noted in regulatory documents as facing an increased risk of severe, potentially fatal, adverse reactions.

Therapeutic Uses of Feminax Express

What Feminax Express Treats: Main Uses and Benefits

The active ingredient in this medication is commonly used across therapeutic domains involving distressing symptoms, including pain, inflammation, and fever. The formulation is relevant when short-term symptomatic assistance and the timely easing of discomfort are commonly sought when symptoms related to acute or episodic changes occur.

This medication is commonly used across conditions presenting with recurrent or episodic manifestations to help manage symptoms related to physical discomfort. Relevant indications include primary menstrual pain (dysmenorrhea) and associated backache, headaches (including migraine pain), dental pain, general muscular aches, and fever associated with cold and flu symptoms.

“The formulation plays a role in managing symptoms related to systemic imbalance by being applied in addressing elevated body temperature.”

Quick Fact: Relief for Episodic Discomfort

The medication may assist with symptoms that interfere with daily functioning, such as acute cramping or localized throbbing. This provides support that helps ease the overall symptom burden, supports general well-being during symptomatic phases, and helps patients cope more steadily with difficult episodes.

Eligibility and Restrictions for Use

Who Can and Cannot Use Feminax Express?

This section outlines the official population eligibility and non-eligibility rules for Feminax Express (Ibuprofen Lysinate), strictly based on government regulatory documentation (Summary of Product Characteristics and Patient Information Leaflets).


Official Eligibility and Contraindications

Classification Rule and Rationale
Eligible Populations Adults and adolescents aged 12 years and over are generally permitted to use the medicine for short-term relief.
Age Restriction Use is contraindicated or not recommended for children under the age of 12 years.
Absolute Contraindications Use is prohibited in individuals with a known allergy or hypersensitivity to ibuprofen, aspirin, or other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
Organ Failure The medicine must not be used by patients with severe heart failure, severe renal failure, or severe hepatic failure.
Gastrointestinal History Contraindicated in patients with active or a history of recurrent peptic ulcers or gastrointestinal bleeding/perforation related to NSAID use.
Pregnancy Status Use is contraindicated during the third trimester of pregnancy.

Conditional Use and Necessary Caution

Caution and consultation with a healthcare professional are required for use in the elderly population, patients with mild to moderate organ impairment, or those with pre-existing conditions like controlled hypertension, specific cardiovascular risk factors, or a history of Crohn’s Disease or Ulcerative Colitis. Use during the first and second trimesters of pregnancy or while breastfeeding is permitted only under medical guidance.

What should I know about interactions with other medicines?

The interaction profile for Feminax Express, which contains Ibuprofen Lysinate, is based on officially documented effects with other medicinal products and substances. Regulatory information establishes restrictions regarding co-administration: the product should be avoided when used concurrently with other NSAIDs, including COX-2 selective inhibitors, and with Methotrexate at high doses, due to toxicity concerns.

A primary interaction risk is additive bleeding, documented when Ibuprofen Lysinate is combined with Anticoagulants (such as Warfarin), Oral Corticosteroids, or Selective Serotonin Reuptake Inhibitors (SSRIs), increasing the likelihood of gastrointestinal bleeding. Furthermore, the anti-platelet effect of low-dose Aspirin may be competitively inhibited, a specific pharmacodynamic interference. To mitigate this, official timing rules require separation: Aspirin must be taken at least two hours before Ibuprofen, or Ibuprofen must be taken eight hours before Aspirin.

Ibuprofen also alters the clearance of certain medicines, a pharmacokinetic effect that increases plasma concentrations of Lithium and Digoxin, necessitating monitoring. The antihypertensive effects of ACE Inhibitors and the natriuretic effect of Diuretics may be reduced. Lastly, the product label notes that combining the medicine with alcohol may increase the frequency of undesirable effects affecting the central or gastrointestinal systems. Specific caution regarding interaction severity is noted for elderly patients.

Mechanism of Action

The mechanism of Feminax Express (Ibuprofen Lysinate) is defined by the action of Ibuprofen. Its function is to modulate the physiological processes involving prostaglandin synthesis and nociceptive signaling.


Molecular Targeting: Reversible Inhibition of COX Enzymes

The drug's core action is the reversible inhibition of the Cyclooxygenase (COX) enzymes, specifically the COX-1 and COX-2 isoforms. This molecular interference prevents the conversion of Arachidonic Acid into powerful signaling molecules, which is the necessary first step to achieve the resulting physiological modulation.


Physiological Cascade: Suppression of Prostaglandin Signaling

By blocking COX enzyme activity, the drug significantly suppresses the biosynthesis of local hormones, chiefly Prostaglandin E2 (PGE2 ), in both peripheral tissues and the central nervous system. This molecular step directly leads to key physiological adjustments, including the decreased sensitization of peripheral nociceptors and the resetting of the hypothalamic temperature set point.


Systemic Outcome: Nociceptive and Thermoregulatory Modulation

This suppression of prostaglandin signaling results in a three-part systemic consequence: the nociceptive threshold is elevated, the suppression of local vascular permeability and exudation, which mediates the anti-inflammatory response, and the resetting of the hypothalamic set point for temperature, which mediates the antipyretic response.

Dosage and Administration Information

How to Use Feminax Express: Administration Guidelines

Feminax Express, containing Ibuprofen Lysinate (equivalent to 200 mg Ibuprofen per tablet), is intended for oral administration and short-term use only. The proper use of this nonsteroidal anti-inflammatory drug (NSAID) is governed by specific dosing and scheduling principles.


Administration Protocol

The fundamental usage principle is to use the lowest effective dose for the shortest duration necessary to relieve symptoms.

Feature Guideline
Dosing Schedule (Adults & Adolescents ge 12 years) The initial dose is 1 or 2 tablets (200 mg or 400 mg Ibuprofen).
Frequency and Interval A repeat dose may be taken every 4 to 6 hours as required, but the interval between doses must be at least four hours.
Maximum Daily Dose Do not exceed 6 tablets (1200 mg Ibuprofen) in any 24-hour period.
Intake Condition Tablets must be swallowed whole with water and not chewed. Patients with a sensitive stomach are recommended to take the tablets with or after food.

Population and Duration Constraints

Specific duration constraints apply based on age:

  • Adults: The medicine is not to be taken for longer than 10 days without consulting a doctor.
  • Adolescents (12-18 years): If the product is required for more than 3 days, or if symptoms worsen, a doctor should be consulted.
  • Children: The medicine is not suitable for children under 12 years of age or adolescents weighing less than 40 kg.

These instructions define the standardized, time-limited use of the medication, ensuring the dose, frequency, and duration align with the framework for this specific oral formulation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Feminax Express

Research Evidence for Acute Symptomatic Relief

The active ingredient in Feminax Express (Ibuprofen Lysinate) was studied for research exploring acute, short-term discomfort, such as headaches and muscular aches. The primary evidence base includes Randomized Controlled Trials (RCTs) and comprehensive systematic reviews. These studies are relevant in trials assessing short-term or episodic symptom patterns and often involve comparisons with a placebo (an inactive substance).

The research examined outcomes related to physical discomfort, focusing on how symptoms evolved in the observed populations. Findings describe patterns observed in the studies, with researchers monitoring for changes in pain intensity scores.

It is important to understand that these study results apply only to the populations studied, which were typically healthy adults experiencing moderate pain in a controlled setting. Comparative evidence is lacking for many different combinations of symptoms.


Evidence for Use in Primary Dysmenorrhea (Menstrual Pain)

The active substance was evaluated in research settings involving primary dysmenorrhea, a condition characterized by fluctuating or episodic manifestations. The evidence for this application largely comes from systematic reviews that pool data from many different RCTs on the active substance. These studies were used in research exploring how symptoms change over time.

The studies monitored outcomes capturing phases of heightened symptom activity, such as patient-reported scores on pain intensity. Research describes patterns related to the reported use of supplementary pain medication during the symptomatic period. Findings indicate that the active substance was observed in some studies as a standard pharmacological approach for this type of episodic discomfort.

Specific questions remain regarding the research on the Lysinate salt formulation. Comparative evidence is lacking from large-scale, head-to-head trials that directly compare the overall total symptom change achieved by the Ibuprofen Lysinate salt against the standard Ibuprofen acid for this indication.

Key Studies & References

  1. Ibuprofen (StatPearls - NCBI Bookshelf - NIH)

Frequently Asked Questions (FAQ)

Common questions about Feminax Express (FAQ)


Q: Is Feminax Express the same as regular Feminax?

According to official product information, Feminax Express contains the active ingredient Ibuprofen in a special salt form called Ibuprofen Lysinate. The Lysinate salt is a formulation design intended to allow for faster absorption into the body compared to the standard Ibuprofen acid often found in regular formulations. This difference primarily relates to the intended speed of action.


Q: Does Feminax Express treat only period pain or other pains too?

Regulatory documents indicate that the medicine is used for the temporary relief of mild to moderate pain. This commonly includes discomfort such as headache, backache, muscle pain, and also menstrual pain. The active ingredient functions as a general analgesic, meaning it can help relieve various types of pain.


Q: How quickly does Feminax Express typically start working?

The 'Express' component refers to the use of Ibuprofen Lysinate, which is formulated for rapid absorption. While individual experience may vary, studies related to the active ingredient indicate a fast onset of action. The medicine is designed to be absorbed more quickly than standard ibuprofen formulations.


Q: How long do the effects of Feminax Express usually last?

The active ingredient has a short elimination half-life. Official administration guidelines recommend repeating a dose, if needed, with an interval of 4 to 6 hours between doses. This interval reflects the manufacturer's recommended re-dosing time based on the active ingredient's profile.


Q: Does Feminax Express cause drowsiness or sleepiness?

Official labeling lists side effects such as dizziness and headache as uncommon occurrences. Although these effects may impact alertness, drowsiness or sedation itself is not usually listed as a common effect in official documentation. Conversely, sleeplessness is listed as an uncommon side effect.


Q: Can Feminax Express be taken with other cold and flu medicines?

Official information advises that this medicine should be avoided when used with any other product that contains the same active ingredient or other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Patients are advised to check the ingredients of all cold and flu medicines before concurrent use.


Q: Has the safety of Feminax Express been studied in long-term use?

Regulatory documents restrict the use of this medicine to short-term relief only (e.g., up to 10 days for adults). Use beyond the recommended time or at high doses is documented to increase the risk of serious side effects, including heart-related events and gastrointestinal bleeding. Patients are advised to adhere to the duration guidelines on the product label.


Q: Does Feminax Express contain aspirin?

The only active ingredient in Feminax Express is Ibuprofen Lysinate. However, it is contraindicated (prohibited) for individuals with a known allergy to aspirin or other NSAIDs. Special regulatory timing rules also apply if a patient is taking low-dose aspirin, and this specific interaction should be noted.


Q: What is the legal classification of Feminax Express (e.g., P medicine, GSL)?

The product is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). It is licensed by regulatory agencies as an Over-The-Counter (OTC) medicine, meaning it can be purchased without a prescription. This classification defines its legal availability.


Q: Are there any known interactions between Feminax Express and birth control pills?

While regulatory labels may not list a direct interaction, studies have associated the combined use of NSAIDs like ibuprofen with hormonal contraceptives with a small increased risk of blood clots (venous thromboembolism). This potential risk should be noted.


Q: Is it safe to take Feminax Express with paracetamol (acetaminophen)?

Official product information does not typically list a direct interaction between ibuprofen and paracetamol. However, users are advised to be cautious when combining any two types of pain relief, and to avoid exceeding the maximum daily dose limits for both medicines.


Q: What happens if I miss a dose of Feminax Express?

Feminax Express is intended for episodic relief rather than continuous therapy. Official guidance generally focuses on resuming use as needed when pain returns, ensuring the minimum time interval between doses is respected. There is no specific instruction provided for 'missed doses'.


Q: What should I do if I experience an unexpected reaction after taking the drug?

Official warnings advise patients to stop use and seek medical help right away if signs of a serious reaction occur. These reactions may include a severe allergy (like facial swelling or hives) or stomach bleeding (like passing black stools or vomiting blood). Consult a doctor if any new, unexpected symptoms develop.


Q: Is Feminax Express considered a strong painkiller?

The active ingredient, Ibuprofen, is generally recognized by clinical authorities for managing mild to moderate pain. While the 'Express' formulation promotes rapid action, the medication is not classified as a potent, opioid-based, or high-strength painkiller typically reserved for severe pain.


Q: Can this medication cause fluid retention?

Yes, regulatory product information documents that the active substance, Ibuprofen, can interfere with the kidney’s ability to regulate salt and water. This can lead to the possibility of fluid retention, or edema, which is a documented side effect.


Q: Does the effectiveness of Feminax Express vary from person to person?

Official efficacy data and clinical trial results are based on averages across large study populations. Therefore, the actual speed and degree of pain relief experienced by an individual may vary, as the body's response to medication is highly individual.


Q: Is Feminax Express a medication that causes dependence?

Ibuprofen, the active ingredient, is classified as an NSAID and is not a controlled substance. It is generally not considered to be habit-forming. However, prolonged or inappropriate use should be avoided.


Q: Does Feminax Express relieve tension or solely the physical pain?

The medication's mechanism of action is primarily to modulate the physiological processes related to inflammation and the perception of physical pain (nociceptive signaling). While this relief may subjectively lessen feelings of physical tension associated with pain, its core function is pharmacological pain relief.


Q: Can this drug cause sensitivity to sunlight?

Though not always listed as a common reaction, the class of medications known as NSAIDs, which includes ibuprofen, has been associated in regulatory reviews with photosensitivity. Photosensitivity means increased sensitivity to sunlight or UV exposure.


Q: What is the half-life of the active ingredient in Feminax Express?

The elimination half-life of the active ingredient, Ibuprofen, is a pharmacokinetic measure that indicates how quickly half of the drug is eliminated from the system. This value is typically reported in official sources to be around 1.9 to 2.2 hours in adults.


Q: Are there any restrictions on driving or operating machinery while using Feminax Express?

Official patient warnings caution that if a patient experiences side effects such as dizziness, vertigo, or drowsiness, they are advised not to drive or operate machinery. It is important to wait until these effects have completely passed before resuming such activities.

How should Feminax Express be stored and disposed of?

How to Store and Dispose of Feminax Express

Official regulatory documents mandate specific conditions for the storage and disposal of Feminax Express (Ibuprofen Lysine) to ensure the product's stability and public safety.

Storage Requirements

Detail Condition
Temperature Store below 30°C (86 F).
Child Safety Must be kept out of the sight and reach of children and animals.
Container Rule Do not use after the expiry date (EXP) shown on the carton.

Disposal Instructions

Proper disposal is required to protect the environment. The product label strictly prohibits discarding unused or expired Feminax Express via wastewater or household waste. Users are instructed to ask a pharmacist for the proper method to throw away medicines no longer in use, ensuring disposal complies with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Feminax Express found in:

A-Z Index: